ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials
Citations
American Society of Hematology. (1).
ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials.
Retrieved from https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials.
American Society of Hematology.
"ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials." Hematology.org.
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials
(label-accessed May 01, 2025).
"American Society of Hematology."
ASH Letter to FDA re Draft Guidance on Decentralized Clinical Trials, 01 May. 2025 ,
https://www.hematology.org/advocacy/testimony-and-correspondence/ash-letter-to-fda-re-draft-guidance-on-decentralized-clinical-trials.